Interventions for valvular disease
Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions February 7, 2020 | 10.4244/EIJ-D-19-00782
Showing 1-7 of 7 articles
Interventions for valvular disease
Reference dimensions to determine valve size of stented surgical aortic bioprostheses by computed tomography February 4, 2020 | 10.4244/EIJ-D-19-00921
Interventions for valvular disease
Bioprosthetic valve fracture performed before versus after valve-in-valve intervention: Insights from bench testing December 23, 2019 | 10.4244/EIJ-D-19-00939
Interventions for valvular disease
Impact of implant depth on hydrodynamic function with the ALLEGRA transcatheter heart valve following valve-in-valve intervention October 15, 2019 | 10.4244/EIJ-D-19-00782
Interventions for valvular disease
Impact of implant depth on hydrodynamic function with the ACURATE neo transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex vivo bench study May 20, 2019 | 10.4244/EIJ-D-18-00947
Increasing awareness of the need to protect the coronary arteries in patients with failed surgical and transcatheter aortic valves
May 20, 2019 | 10.4244/EIJV15I1A3
Interventions for valvular disease
First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system February 7, 2019 | 10.4244/EIJ-D-18-00935